Complexities of complex II: A versatile architecture for respiration

复合体 II 的复杂性:呼吸的多功能架构

基本信息

  • 批准号:
    7767691
  • 负责人:
  • 金额:
    $ 26.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2012-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Complex II is one of the four electron transfer enzymes that generate the transmembrane electrochemical gradient in mitochondrial aerobic respiration. Its genetic alteration or inhibition has a significant effect on survival of the organism. The complex II superfamily is perhaps the most versatile respiratory enzyme since it is involved in aerobic and anaerobic respiration and the Krebs cycle. The recycling of the complex II architecture for multiple purposes suggests that this fold is evolutionary ancient. Examination of this single enzyme can give insight into biological mechanisms of fumarate reduction, succinate oxidation, aspartate oxidation, quinol chemistry, electron transfer, and the formation of the transmembrane electrochemical gradient. In preliminary studies, the complex II homolog quinol:fumarate reductase has been overproduced, crystallized and the structure determined alone and in complex with inhibitors of the quinol-binding site. Further, the structures of several mutagenic variants have been determined, revealing unexpected conformational rearrangements that give insight into enzyme activity. These preliminary results allowed us to generate a hypothesis for the catalytic reaction mechanism and that includes accompanying conformational motion. This sets the stage for the Aims of this proposal: In Aim 1, we will describe the chemical details of catalysis at the dicarboxylate-binding site. To achieve this, we will co-crystallize the quinol:fumarate reductase (QFR) with multiple small molecules and structurally investigate mutants that alter the catalytic efficiency. In Aim 2, we will characterize the motions associated with catalysis. We have already classified enzyme motions into three distinct types - interdomain motions, motions of a catalytic loop, and global motions. We have begun structural characterization of a site-directed mutant that interrupts normal domain motion. Complemented by computational methods that evaluate the energies of each trapped state, we will further characterize the large, interdomain motion using a combination of site-directed spin labeling and electron paramagnetic resonance spectroscopy. In Aim 3, we will investigate the influence of environmental fungicides on the catalytic activity of complex II. Here, we will co-crystallize several quinol-binding inhibitors with both the wild type E. coli QFR and a variant of the E. coli QFR that has fungicide binding properties similar to the human enzyme. We will further work to express human complex II with a heterologous system for structural studies.
描述(由申请人提供):复合物II是在线粒体有氧呼吸中产生跨膜电化学梯度的四种电子转移酶之一。它的遗传改变或抑制对生物体的存活具有显著影响。复合体II超家族可能是最通用的呼吸酶,因为它参与有氧和无氧呼吸以及克雷布斯循环。复合体II结构的再循环用于多种目的表明,这种褶皱是进化古老的。这种单一的酶的检查,可以给洞察反丁烯二酸盐还原,琥珀酸氧化,天冬氨酸氧化,醌醇化学,电子转移,和跨膜电化学梯度的形成的生物机制。在初步研究中,复杂的II同系物醌醇:延胡索酸还原酶已被过度生产,结晶和结构确定单独和复杂的抑制剂的喹啉结合位点。此外,已经确定了几种诱变变体的结构,揭示了意想不到的构象重排,从而深入了解酶的活性。这些初步结果使我们能够产生一个假设的催化反应机制,包括伴随的构象运动。这为该提案的目标奠定了基础:在目标1中,我们将描述在二羧酸结合位点催化的化学细节。为了实现这一目标,我们将使醌醇:富马酸还原酶(QFR)与多种小分子共结晶,并从结构上研究改变催化效率的突变体。在目标2中,我们将描述与催化相关的运动。我们已经将酶的运动分为三种不同的类型--域间运动、催化环运动和全局运动。我们已经开始了一个定点突变,中断正常域运动的结构特征。通过计算方法,评估每个被困状态的能量的补充,我们将进一步表征的大,域间运动使用的组合的定点自旋标记和电子顺磁共振光谱。在目标3中,我们将研究环境杀真菌剂对配合物II的催化活性的影响。在这里,我们将共结晶几个喹啉结合抑制剂与野生型E。coli QFR和E. coli QFR,其具有与人类酶类似的杀真菌剂结合特性。我们将进一步的工作,表达人类复合物II的异源系统的结构研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

T M Iverson其他文献

T M Iverson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('T M Iverson', 18)}}的其他基金

Training in Pharmacological Sciences
药理学培训
  • 批准号:
    10625697
  • 财政年份:
    2023
  • 资助金额:
    $ 26.29万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10438835
  • 财政年份:
    2020
  • 资助金额:
    $ 26.29万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10653008
  • 财政年份:
    2020
  • 资助金额:
    $ 26.29万
  • 项目类别:
Engineered probes for sialoglycan detection
用于唾液酸聚糖检测的工程探针
  • 批准号:
    10266164
  • 财政年份:
    2020
  • 资助金额:
    $ 26.29万
  • 项目类别:
Molecular basis for arrestin-mediated signaling
抑制蛋白介导的信号传导的分子基础
  • 批准号:
    9324338
  • 财政年份:
    2016
  • 资助金额:
    $ 26.29万
  • 项目类别:
Mechanisms for ligand binding by serine-rich adhesins of Gram-positive pathogens
革兰氏阳性病原体富含丝氨酸的粘附素的配体结合机制
  • 批准号:
    8788229
  • 财政年份:
    2014
  • 资助金额:
    $ 26.29万
  • 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
  • 批准号:
    8362282
  • 财政年份:
    2011
  • 资助金额:
    $ 26.29万
  • 项目类别:
Crystallographic Automation
晶体学自动化
  • 批准号:
    7793204
  • 财政年份:
    2010
  • 资助金额:
    $ 26.29万
  • 项目类别:
Stabilization of Membrane Protein Signaling Complexes
膜蛋白信号复合物的稳定性
  • 批准号:
    8310115
  • 财政年份:
    2010
  • 资助金额:
    $ 26.29万
  • 项目类别:
STRUCTURAL STUDIES OF TRANSMEMBRANE SIGNALING COMPLEXES AND NOVEL THERAPEUTIC AG
跨膜信号复合物和 NOVEL THERAPEUTIC AG 的结构研究
  • 批准号:
    8170283
  • 财政年份:
    2010
  • 资助金额:
    $ 26.29万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 26.29万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了